Pharma News, 2025

Biocon Biologics Says FDA Approves Bosaya And Aukelso As Denosumab Biosimilars

Nurix reports promising preclinical data for IRAK4 degrader GS-6791

The company’s commitment covers capital spending across its US supply chain and funding for drug discovery, development and trials.

Gyala Therapeutics unveils first-in-class CAR-T therapy targeting CD84 showing strong preclinical efficacy in hard-to-treat leukemias

Corstasis Therapeutics Announces FDA Approval of ENBUMYST™ (bumetanide nasal spray) for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease

Biomea Fusion Presents Data Demonstrating Enhanced Preclinical Activity of Icovamenib in Combination with Semaglutide in Type 2 Diabetes (T2D) Animal Model at the 61st EASD Annual Meeting and ...

Novartis returns to Monte Rosa for second time in a year with $5.7bn deal

US-based Amneal Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for its 500mg/mL sodium oxybate oral solution.

LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut

Artificial intelligence accelerates drug discovery and reduces animal testing

Polyrizon reports positive preclinical results for nasal allergy blocker

The feature will reportedly be available in 150 countries when it starts shipping on September 19.